The company provides logistics and supply chain solutions, primarily road transportation and freight services, alongside a smaller travel and tourism division.
The company operates in a highly fragmented and commoditized transport sector with no evidence of pricing power, as net margins are razor-thin (under 2%) and ROCE is mediocre. The negative cash conversion and high reliance on short-term debt to fund working capital suggest a lack of structural competitive advantage.
Capital is primarily tied up in working capital and trade receivables rather than productive reinvestment. The company carries significant debt (D/E 1.5) and has recently increased borrowing to fund operations despite declining profitability, while paying out significant managerial remuneration relative to net profit.
The company's collapse was driven by a liquidity trap where negative cash conversion and razor-thin margins finally collided with rising interest costs. As the NCLT debt recovery petition progressed, credit lines tightened, forcing the firm to liquidate assets at a loss to service a debt load that its 1.5x interest coverage could no longer support. The Sethia family continued to prioritize their own remuneration while the business bled, eventually leading to a total loss of equity value as the asset reconstruction company took control of the remaining receivables.
RichFakir rates Balurghat Technologies Ltd's business quality as poor — 14/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Balurghat Technologies Ltd is trading about 67% above our estimate of fair value; we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Balurghat Technologies Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Balurghat Technologies Ltd's fair value is about ₹7 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →